Steroid Metabolomic Signature of Insulin Resistance in Childhood Obesity

被引:18
作者
Gawlik, Aneta M. [1 ]
Shmoish, Michael [2 ]
Hartmann, Michaela F. [3 ]
Wudy, Stefan A. [3 ]
Hochberg, Ze'ev [4 ]
机构
[1] Med Univ Silesia, Dept Pediat & Pediat Endocrinol, Sch Med Katowice, Upper Silesia Childrens Care Hlth Ctr, Katowice, Poland
[2] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Haifa, Israel
[3] Justus Liebig Univ Giessen, Steroid Res & Mass Spectrometry Unit, Div Pediat Endocrinol & Diabetol, Ctr Child & Adolescent Med, Giessen, Germany
[4] Technion Israel Inst Technol, Fac Med, Haifa, Israel
关键词
ENDOTHELIAL DYSFUNCTION; DEHYDROGENASE TYPE-1; ALDOSTERONE; LEPTIN; MODEL; GLUCOCORTICOIDS; DEFINITION; MECHANISMS; EXPRESSION; CHILDREN;
D O I
10.2337/dc19-1189
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE On the basis of urinary steroidal gas chromatography-mass spectrometry (GC-MS), we previously defined a novel concept of a disease-specific "steroid metabolomic signature" and reclassified childhood obesity into five groups with distinctive signatures. The objective of the current study was to delineate the steroidal signature of insulin resistance (IR) in obese children. RESEARCH DESIGN AND METHODS Urinary samples of 87 children (44 girls) aged 8.5-17.9 years with obesity (BMI >97th percentile) were quantified for 31 steroid metabolites by GC-MS. Defined as HOMA-IR >95th percentile and fasting glucose-to-insulin ratio >0.3, IR was diagnosed in 20 (of 87 [23%]) of the examined patients. The steroidal fingerprints of subjects with IR were compared with those of obese children without IR (non-IR). The steroidal signature of IR was created from the product of IR - non-IR for each of the 31 steroids. RESULTS IR and non-IR groups of children had comparable mean age (13.7 +/- 1.9 and 14.6 +/- 2.4 years, respectively) and z score BMI (2.7 +/- 0.5 and 2.7 +/- 0.5, respectively). The steroidal signature of IR was characterized by high adrenal androgens, glucocorticoids, and mineralocorticoid metabolites; higher 5 alpha-reductase (An/Et) (P = 0.007) and 21-hydroxylase [(THE + THF + alpha THF)/PT] activity (P = 0.006); and lower 11 beta HSD1 [(THF + alpha THF)/THE] activity (P = 0.012). CONCLUSIONS The steroidal metabolomic signature of IR in obese children is characterized by enhanced secretion of steroids from all three adrenal pathways. As only the fasciculata and reticularis are stimulated by ACTH, these findings suggest that IR directly affects the adrenals. We suggest a vicious cycle model, whereby glucocorticoids induce IR, which could further stimulate steroidogenesis, even directly. We do not know whether obese children with IR and the new signature may benefit from amelioration of their hyperadrenalism.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 32 条
[1]   Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents [J].
Allard, P ;
Delvin, EE ;
Paradis, G ;
Hanley, JA ;
O'Loughlin, J ;
Lavallée, C ;
Levy, E ;
Lambert, M .
CLINICAL CHEMISTRY, 2003, 49 (04) :644-649
[2]   Effects of the 11β-hydroxysteroid dehydrogrenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes [J].
Andrews, RC ;
Rooyackers, O ;
Walker, BR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :285-291
[3]   Insulin, renin-aldosterone system and blood pressure in obese people [J].
Andronico, G ;
Cottone, S ;
Mangano, MT ;
Ferraro-Mortellaro, R ;
Baiardi, G ;
Grassi, N ;
Ferrara, L ;
Mulé, G ;
Cerasola, G .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (02) :239-242
[4]   Mineralocorticoid Receptor-Mediated Vascular Insulin Resistance An Early Contributor to Diabetes-Related Vascular Disease? [J].
Bender, Shawn B. ;
McGraw, Adam P. ;
Jaffe, Iris Z. ;
Sowers, James R. .
DIABETES, 2013, 62 (02) :313-319
[5]   Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways Implications in Diabetes Mellitus-Associated Obesity and Vascular Dysfunction [J].
Briones, Ana M. ;
Cat, Aurelie Nguyen Dinh ;
Callera, Glaucia E. ;
Yogi, Alvaro ;
Burger, Dylan ;
He, Ying ;
Correa, Jose W. ;
Gagnon, Anne Marie ;
Gomez-Sanchez, Celso E. ;
Gomez-Sanchez, Elise P. ;
Sorisky, Alexander ;
Ooi, Teik Chye ;
Ruzicka, Marcel ;
Burns, Kevin D. ;
Touyz, Rhian M. .
HYPERTENSION, 2012, 59 (05) :1069-+
[6]  
Cutfield Wayne S, 2003, Pediatr Diabetes, V4, P119, DOI 10.1034/j.1399-5448.2003.t01-1-00022.x
[7]   Expression and activity of the cortisol-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 is tissue and species-specific [J].
Dammann, Christine ;
Stapelfeld, Claudia ;
Maser, Edmund .
CHEMICO-BIOLOGICAL INTERACTIONS, 2019, 303 :57-61
[8]   Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications [J].
Diamanti-Kandarakis, Evanthia ;
Dunaif, Andrea .
ENDOCRINE REVIEWS, 2012, 33 (06) :981-1030
[9]   Increased Aldosterone Levels in a Model of Type 2 Diabetes Mellitus [J].
Fredersdorf, S. ;
Endemann, D. H. ;
Luchner, A. ;
Heitzmann, D. ;
Ulucan, C. ;
Birner, C. ;
Schmid, P. ;
Stoelcker, B. ;
Resch, M. ;
Muders, F. ;
Riegger, G. Aj ;
Weill, J. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2009, 117 (01) :15-20
[10]   Steroid metabolomic signature of liver disease in nonsyndromic childhood obesity [J].
Gawlik, Aneta ;
Shmoish, Michael ;
Hartmann, Michaela F. ;
Wudy, Stefan A. ;
Olczak, Zbigniew ;
Gruszczynska, Katarzyna ;
Hochberg, Ze'ev .
ENDOCRINE CONNECTIONS, 2019, 8 (06) :764-771